Recent studies have found that SHP2, which interacts with FLT3-ITD phosphorylated Gab2, is involved in activating the MEK/ERK pathway, as well as RSK's negative feedback regulation of that pathway in FLT3-ITD-positive AML cells. This evidence concerns the gene FLT3 and acute myeloid leukemia.